Author

Meeran Atta

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Oct 2026

CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis

Introduction Semaglutide 2.4 mg is the reference pharmacotherapy for weight management, yet many patients do not reach ambitious weight-loss targets. CagriSema, a fixed-dose combination of cagrilintide and semaglutide, may offer additional benefit through complementary mechanisms. We quantified its incremental efficacy...

Zehra Khatoon Rasool, Rajvi K. Shah, Ansharah E. Zinnia Batool et al. · Frontiers in Endocrinology · 0 citations

Open access Sep 2026

Preoperative SGLT2 Inhibitor Use and Outcomes After Major Cardiac Procedures: A Propensity Score-Matched Analysis of the TriNetX Network

Background/Objectives: Sodium–glucose cotransporter-2 (SGLT2) inhibitors improve cardiorenal outcomes in patients with diabetes, heart failure, and chronic kidney disease. Their association with perioperative outcomes after major cardiac procedures remains uncertain. Methods: In this retrospective cohort study using th...

Mirza Muhammad Hadeed Khawar, Faizan Ahmed, M. Elnashar et al. · Journal of Clinical Medicine · 0 citations

Open access Jul 2026

CORRELATION OF HBA1C WITH LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

HbA1c was significantly associated with lipid abnormalities in patients with type 2 diabetes mellitus and may serve as a useful marker for identifying patients at increased cardiovascular risk.

Hashmat Ullah Khan, Hafiz Bilal Hassan, Meeran Atta et al. · Genetics and Molecular Resea... · 0 citations